Bayesian continual reassessment method for dose-finding trials infusing t cells with limited sample size

导出原文传递

翻译打印收藏纠错

作者： Ji, Y. ^[1] ; Feng, L. ^[2] ; Liu, P. ^[3] ; Shpall, E.J. ^[4] ; Kebriaei, P. ; Champlin, R. ; Berry, D. ; Cooper, L.J.N.

作者单位： Stem Cell Transplantation and Cellular Therapy Program, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States ^[1] Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States ^[2] Department of Statistics, Rice University, PO Box 1892, Houston, TX 77251-1892, United States ^[3] Division of Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States ^[4]

关键词 Adaptive designs Phase I Toxicity

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Journal of biopharmaceutical statistics

2012年22卷6期

1206-1219页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Bayesian continual reassessment method for dose-finding trials infusing t cells with limited sample size

Journal of biopharmaceutical statistics

相似文献

Journal of biopharmaceutical statistics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Bayesian continual reassessment method for dose-finding trials infusing t cells with limited sample size

Journal of biopharmaceutical statistics

相似文献

Journal of biopharmaceutical statistics

相关期刊

检索历史清除